Goldman Sachs Group Inc Revolution Medicines, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,354,602 shares of RVMD stock, worth $102 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,354,602
Previous 1,448,095 62.6%
Holding current value
$102 Million
Previous $56.2 Million 89.83%
% of portfolio
0.02%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$36.92 - $47.94 $33.5 Million - $43.5 Million
906,507 Added 62.6%
2,354,602 $107 Million
Q2 2024

Aug 13, 2024
BUY
$30.14 - $40.68 $9.78 Million - $13.2 Million
324,645 Added 28.9%
1,448,095 $56.2 Million
Q1 2024

May 15, 2024
BUY
$26.56 - $33.55 $1.86 Million - $2.35 Million
70,193 Added 6.66%
1,123,450 $36.2 Million
Q4 2023

Feb 13, 2024
BUY
$18.35 - $34.12 $7.81 Million - $14.5 Million
425,812 Added 67.86%
1,053,257 $30.2 Million
Q3 2023

May 14, 2024
SELL
$25.17 - $35.05 $10.7 Million - $14.9 Million
-425,812 Reduced 40.43%
627,445 $17.4 Million
Q3 2023

Nov 14, 2023
SELL
$25.17 - $35.05 $1.77 Million - $2.46 Million
-70,234 Reduced 10.07%
627,445 $17.4 Million
Q2 2023

May 14, 2024
SELL
$20.28 - $27.0 $8.89 Million - $11.8 Million
-438,379 Reduced 38.59%
697,679 $18.7 Million
Q2 2023

Aug 14, 2023
SELL
$20.28 - $27.0 $8.89 Million - $11.8 Million
-438,379 Reduced 38.59%
697,679 $18.7 Million
Q1 2023

May 14, 2024
BUY
$20.76 - $30.09 $2.8 Million - $4.06 Million
134,841 Added 13.47%
1,136,058 $24.6 Million
Q1 2023

May 11, 2023
BUY
$20.76 - $30.09 $2.8 Million - $4.06 Million
134,841 Added 13.47%
1,136,058 $24.6 Million
Q4 2022

May 14, 2024
SELL
$17.68 - $25.53 $693,215 - $1 Million
-39,209 Reduced 3.77%
1,001,217 $23.8 Million
Q4 2022

Feb 13, 2023
SELL
$17.68 - $25.53 $693,215 - $1 Million
-39,209 Reduced 3.77%
1,001,217 $23.8 Million
Q3 2022

May 14, 2024
BUY
$17.46 - $26.0 $2.64 Million - $3.92 Million
150,929 Added 16.97%
1,040,426 $20.5 Million
Q3 2022

Nov 10, 2022
BUY
$17.46 - $26.0 $2.64 Million - $3.92 Million
150,929 Added 16.97%
1,040,426 $20.5 Million
Q2 2022

May 14, 2024
SELL
$14.54 - $27.17 $2.38 Million - $4.45 Million
-163,760 Reduced 15.55%
889,497 $17.3 Million
Q2 2022

Aug 15, 2022
BUY
$14.54 - $27.17 $290,654 - $543,128
19,990 Added 2.3%
889,497 $17.3 Million
Q1 2022

May 16, 2022
BUY
$17.31 - $26.4 $3.03 Million - $4.63 Million
175,304 Added 25.25%
869,507 $22.2 Million
Q4 2021

Feb 14, 2022
SELL
$24.35 - $33.7 $6.81 Million - $9.43 Million
-279,695 Reduced 28.72%
694,203 $17.5 Million
Q3 2021

Nov 10, 2021
BUY
$23.95 - $33.41 $23.3 Million - $32.5 Million
973,898 New
973,898 $26.8 Million

Others Institutions Holding RVMD

# of Institutions
266
Shares Held
161M
Call Options Held
260K
Put Options Held
620K
View Full List

About Revolution Medicines, Inc.

RVMD Quotes by TradingView
  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email